Cancer Drugs Approved Quickly Often Fail To Measure Up Later
Regulators give many cancer drugs a fast track to market while requiring drugmakers to do more studies after approval. Researchers have found the follow-up studies frequently come up short.
Read more on NPR
Health Care - May 29, 2019 at 12:56AM - Cancer Drugs Approved Quickly Often Fail To Measure Up Later
Không có nhận xét nào:
Đăng nhận xét